Successful Treatment of SARS-CoV2 Delta Variant Infected Patient with a Monoclonal Antibody Cocktail

Abstract We report the successful effect of mAbs therapy against SARS-CoV-2 Delta variant (also known as B.1.617.2) in a woman aged 59, affected by secondary immunodepression due to a rheumatoid arthritis currently treated with biological drugs. Keywords Delta variant; Monoclonal antibodies; SARS-CoV-2